论文部分内容阅读
本刊讯4月7日,华邦生命健康股份有限公司(以下简称“华邦健康”)发布了2016年度业绩快报修正公告,称预计2016年实现营业总收入709278.00万元,相比去年同期增加91847.43万元,同比增长14.88%;实现营业利润65778.94万元,比去年同期减少9497.24万元,同比减幅12.62%;实现归属于上市公司股东的净利润56686.83万元,比去年同期减少6975.71万元,同比减幅-10.96%。
On April 7, Winbond Life and Health Co., Ltd. (hereinafter referred to as “Winbond Health”) released the Notice of Correction for 2016 Annual Results Bulletin, saying that it expects to achieve total revenue of RMB7,092,780,000 in 2016. Compared with the previous year An increase of 918.4743 million yuan over the same period, an increase of 14.88%; operating profit of 657.7894 million yuan, a decrease of 94.97224 million yuan over the same period last year, a decrease of 12.62%; net profit attributable to shareholders of listed companies 566,868,300 yuan, representing a decrease of 6,975.71 Million, down -10.96%.